Post CCT Fellow (eqv to ST8+) in Neuro-oncology | Barts Health NHS Trust

The Royal London Hospital & Queen’s Hospital, Romford

Start Date

2026 or 2027 (flexible)

Salary

The salary is based on your nodal point on the MN37 payscale. The banding for this job is currently 50%.

We are recruiting for both 2026 and/or 2027 fellowships.

WeCare about excellence

Barts Health NHS Trust, in partnership with Barking, Havering & Redbridge University Hospitals NHS Trust, is offering an exceptionalSenior Neuro-oncology Fellowship. This 12-month post provides advanced subspecialist training across two busy neurosurgical units, covering a combined catchment of over 4 million people.

Please be advised that the vacancy advertisement may close early if a sufficient number of applications are received therefore, we recommend that you submit your application as soon as possible to avoid disappointment

For further information or an informal discussion, please contact

Prof Dimitrios Paraskevopoulos – Consultant Neurosurgeon & Clinical Lead d.paraskevopoulos@nhs.net

Ms Grainne McKenna – Consultant Neurosurgeon & Clinical Director

grainnesusan.mckenna@nhs.net

Mr Babar Vaqas – Consultant Neurosurgeon

babar.vaqas2@nhs.net

Barts Health supports The Pregnancy Loss Pledge and commits to supporting their staff through the distress of miscarriage.

On call and emergency operating

In addition to the general neurosurgical on call at The Royal London Hospital, as a senior fellow supervising an ST3 trainee out of hours, the Neuro-oncology Fellow will take an active interest in acutely referred oncology cases, coordinating their neurosurgical care.

Neuro-oncology Ward Patients

The Neuro-oncology Fellow will regularly review pre- and post-operative neuro-oncology patients.

Neuro-oncology Clinics

The Neuro-oncology Fellow will regularly attend the weekly multidisciplinary Neuro-oncology Clinic held at St Bartholemew’s Hospital.

Neuro-oncology MDT

The fellow will actively participate in the weekly joint BHR/Barts Neuro-oncology MDT, including vetting referrals and supporting the MDT coordinator.

The full job description provides an overview of the key tasks and responsibilities of the role, and the person specification outlines the qualifications, skills, experience, and knowledge required. For both documents, please view the attachment/s below.

Barts Health is one of the largest NHS trusts in the country, and one of Britain’s leading healthcare providers.

Our vision is to be a high-performing group of NHS hospitals, renowned for excellence and innovation, and providing safe and compassionate care to our patients in east London and beyond. That means being a provider of excellent patient safety, known for delivering consistently high standards of harm-free care and always caring for patients in the right place at the right time. It also means being an outstanding place to work, in which our WeCare values and behaviours are visible to all and guide us in how we work together.

We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.

Clinical Governance

The Neuro-oncology Fellow is expected to prepare and present cases at morbidity and mortality meetings and undertake/supervise clinical audit. All surgical morbidities are reviewed in the monthly Neurosurgery M&M meeting.

Elective Operating

The Neuro-oncology fellow will be trained to perform the full gamut of neurosurgical procedures expected of a ‘Day One’ consultant with a special interest in Neuro-oncology, including craniotomy for intra-axial and extra-axial tumours (including the use of 5-amino levulinic acid fluorescence, intra-operative neurophysiological monitoring and awake craniotomy), biopsy for intra-axial tumour and neuro-endoscopic procedures. In addition, they will gain exposure to the operative management of deep-seated lesions such as intraventricular and circum-ventricular lesions and brainstem tumours.

This advert closes on Thursday 22 Oct 2026